tradingkey.logo
tradingkey.logo
検索

Artivion Inc

AORT
ウォッチリストに追加
23.970USD
+0.420+1.78%
終値 07/02, 13:00ET15分遅れの株価
1.16B時価総額
93.41直近12ヶ月PER

詳細情報 Artivion Inc 企業名

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Artivion Incの企業情報

企業コードAORT
会社名Artivion Inc
上場日Feb 12, 1993
最高経営責任者「CEO」Mackin (James Patrick)
従業員数1600
証券種類Ordinary Share
決算期末Feb 12
本社所在地1655 Roberts Boulevard N W
都市KENNESAW
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号30144
電話番号17704193355
ウェブサイトhttps://artivion.com/
企業コードAORT
上場日Feb 12, 1993
最高経営責任者「CEO」Mackin (James Patrick)

Artivion Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
76.22K
+9.94%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
61.37K
+12.34%
Mr. Andrew M. Green
Mr. Andrew M. Green
Vice President - Regulatory Affairs
Vice President - Regulatory Affairs
60.26K
+44.40%
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
39.13K
+34.61%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%

よくある質問

Artivion Incの上位5名の株主は誰ですか?

Artivion Incの上位5名の株主は以下のとおりです。Mr. John E. Davis

Artivion Inc(AORT)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Artivion Incの株式を保有している機関は449社あり、保有株式の総市場価値は約45.29Mで、全体の93.40%を占めています。2025Q4と比較して、機関の持ち株は501666.00増加しています。

Artivion Incの最大の収益源は何ですか?

2026Q1において、Aortic stent grafts部門がArtivion Incにとって最大の収益を生み出しており、その金額は159.37Mで、全収益の36.11%を占めています。